The next big thing

Innovation Fields

At the Innovation Center, we are investing in forward-looking ideas. By analyzing current mega-trends, we identify Innovation Fields in which we see potential for new business.

Bio-sensing and Interfaces

Our Innovation Field “Bio-sensing and Interfaces” focuses on the interface between the biological and digital world. Around the world, healthcare costs have reached all-time highs, the pharmaceutical industry productivity is decreasing and drugs are becoming more expensive. This situation is unsustainable in the long run. Digital technologies have an enormous potential in delivering the needed change: Within our Innovation Field, we aim to decentralize and democratize the healthcare model and empower patients to better manage their health.

 

Imagine the possibilities!
  • Real-time remote monitoring enabling decentralized healthcare
  • Medical treatment tailored and adaptive to patient condition
  • Measurement of and response to external stimuli and metabolic reactions
  • Decrease of side effects
  • Improving the patient’s quality of life
  • Outcome- and value-based treatments
What are we looking for?
  • Bio-sensing modalities that can be used in a decentralized way, such as sensors in patches, VOC sensors, ingestible or implantable sensors and devices for mobiles
  • Data analytics, utilizing the data collected in a regulatory compliant way. Here, we are looking to partner with companies who can help make healthcare data tangible and manageable using novel data analytics to extract insights.
  • Actions within our therapeutic areas of expertise, such as autoimmune diseases, neurology, fertility, oncology, cardiovascular health and diabetes.
Clean Meat

Due to our rapidly expanding global population and inefficient animal agriculture practices that contribute to climate change and diseases, the need to create “clean”, humane and sustainably produced animal proteins is now greater than ever. Our Innovation Field “Clean Meat” – also referred to as cultured meat or in lab-grown meat – focuses on the biotechnology required to produce genuine meat grown in vitro. This will enable the production of meat that is healthier, more efficiently produced, ethical and environmentally sustainable.

 

Imagine the possibilities!
  • Eat meat without guilt: clean meat production will use less land and water, generate lesser greenhouse gases and remove animal suffering
  • Better nutrition: Chicken with an extra boost of vitamins, beef enriched with omega-3 or mercury-free tuna
What are we looking for?
  • Technologies to enable economically viable, large-scale production of clean meat and seafood such as animal component-free media, high-yield cell line development, industrial bioreactors or automation platforms
  • Technologies similar to tissue engineering and regenerative medicine, to enable next-generation of structured meat products such as edible scaffolds/biomaterials, 3D cell culture processes or 3D printing
Liquid Biopsy Technologies

Today, the diagnoses of various diseases require invasive tissue biopsies, which not only affect patient experience and clinical utility but also disable new applications such as early detection and monitoring. With the recent advent of liquid biopsy as a new sampling and testing method, non-invasive alternatives to traditional tissue-based diagnostics are beginning to be applied more and more in clinical contexts, thereby reshaping the way of detecting and managing various diseases. Our Innovation Field “Liquid Biopsy Technologies” focuses on technological solutions to overcome unresolved challenges in the liquid biopsy workflow as well as on applications beyond cancer.

 

Imagine the possibilities!
  • Non-invasive diagnosis and patient monitoring
  • Individualized treatment selection in cancer and beyond
  • Detection of diseases early before symptoms appear
What are we looking for?
  • New technologies that help overcome bottlenecks in the liquid biopsy workflow such as the isolation of specific body fluid components or biomarkers
  • Liquid biopsies for indications beyond oncology where existing diagnosis or surveillance methods are inadequate and have significant limitations due to their invasiveness 

Create the NEXT BIG THING with us

 

We are looking for partnerships to create sustainable new businesses within our Innovation Fields. Interested?
Contact us at corporate-partnering@emdgroup.com